Eisai Company Ltd
(OTC: ESAIY)
|
4:59 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $9.83 | Change: -0.36 | %Change: -3.53% | Volume: 1,206,731 |
Open: | $ 10.04 | Volume: | 1,206,731 | |
---|---|---|---|---|
High: | $ 10.06 | Yield(%) | 2.06 | |
Low: | $ 9.82 | P/E Ratio (ttm): | 40.14 | |
Dividend ($): | 0.08 | Market Cap ($): | 11.78B | |
EPS ($) | 0.26 | Shares Out: | 1.15B |
% Price Change (last 4 weeks): | -8.73 |
---|---|
% Price Change (last 13 weeks): | 2.15 |
% Price Change (last 26 weeks): | -17.39 |
% Price Change (last 52 weeks): | -39.84 |
% Price Change (year to date): | -17.95 |
Return on Equity (%): | 4.97 |
---|---|
Return on Assets (%): | 3.14 |
Return on Invested Capital (%): | 7.69 |
Gross Profit Margin (%): | 76.01 |
---|---|
Net Profit Margin (%): | 5.72 |
Operating Profit Margin (%): | 6.30 |
|
|
50-day Moving Average: | $10.47 |
---|---|
200-day Moving Average: | $11.68 |
Avg. Daily Vol. (last 50 days): | 103,589 |
Avg. Daily Vol. (last 200 days): | 88,652 |
52-wk high: | $18.87 |
52-wk low: | $9.31 |
Bid: | $n/a |
Ask: | $n/a |
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
|
Eisai Company Ltd
4-6-10 Koishikawa Bunkyo-Ku Tokyo TY 112-8088 Phone: 81.3.3817.3700 Fax: n/a http://www.eisai.co.jp |
Earnings (1year) ($): | 0.26 |
---|---|
Annual Dividend ($): | 0.21 |
Current P/E Ratio (ttm): | 40.14 |
Book Value ($): | 5.04 |
Cash Flow ($): | 0.49 |
Price/Earnings (x): | 40.14 |
---|---|
Price/Sales (x): | 2.30 |
Price/Book (x): | 2.04 |
Price/Cash Flow (x): | 30.49 |
Quick Ratio (x): | 1.80 |
---|---|
Current Ratio (x): | 2.37 |
LT Debt/Equity (x): | 19.70 |
Total Debt/Equity (x): | 23.61 |